Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma
Sean R. Williamson(Cleveland Clinic), Jason L. Hornick(Harvard University), Rodolfo Montironi(Marche Polytechnic University), John N. Eble(Indiana University – Purdue University Indianapolis), Steven C. Smith(Virginia Commonwealth University), Lynette M. Sholl(Brigham and Women's Hospital), Nilesh Gupta(Henry Ford Health System), Michelle S. Hirsch(Perinatal Institute)
Cited by 227
Related Papers
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
|Nature Reviews Clinical Oncology|2021|1.5k
Classification of renal cell carcinoma
|Cancer|1997|878
Crizotinib in<i>ALK</i>-Rearranged Inflammatory Myofibroblastic Tumor
|New England Journal of Medicine|2010|871
The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
|The American Journal of Surgical Pathology|2020|705
Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors
|Nature Genetics|2018|701